Literature DB >> 19626593

Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer.

Sara Vargas1, William K Wohlgemuth, Michael H Antoni, Suzanne C Lechner, Heather A Holley, Charles S Carver.   

Abstract

OBJECTIVE: The current study aimed to determine the frequency of sleep disturbances in women prior to adjuvant therapy for breast cancer (BCa), and whether greater sleep dysfunction uniquely predicts poorer functional outcomes.
METHOD: We assessed subjective sleep reports and associated them with multiple indicators of psychosocial adaptation in 240 women with Stage I-III BCa before they had begun adjuvant treatment.
RESULTS: The average global score on the Pittsburgh Sleep Quality Index (PSQI) was 8.49 (SD=4.16); 54% scoring above the suggested adjusted cutoff for cancer populations of 8.0. Controlling for various medical, sociodemographic, and psychosocial covariates, multiple regression analyses revealed that higher global PSQI score was significantly associated with poorer functional well-being, greater fatigue intensity, greater disruptions in social interactions, and lower positive states of mind. Specifically, a poorer 'sleep efficiency' PSQI component was associated with poorer functional quality of life and the SIP-Social Interactions subscale, while a poorer 'sleep quality' (SQ) PSQI component was associated with all of the outcomes except for the SIP-Recreations and Pastimes subscale.
CONCLUSIONS: Results indicate consistent associations between a clinical indicator of sleep dysfunction, particularly those subscales of the PSQI comprising the 'SQ' component, and multiple indicators of psychosocial adaptation among women treated for BCa, independent of anxiety and depression, and suggest the value of comprehensive psychosocial interventions that consider sleep problems. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19626593      PMCID: PMC2880210          DOI: 10.1002/pon.1603

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  19 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  How stress management improves quality of life after treatment for breast cancer.

Authors:  Michael H Antoni; Suzanne C Lechner; Aisha Kazi; Sarah R Wimberly; Tammy Sifre; Kenya R Urcuyo; Kristin Phillips; Stefan Glück; Charles S Carver
Journal:  J Consult Clin Psychol       Date:  2006-12

3.  Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.

Authors:  Sonia Ancoli-Israel; Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Georgia Robins Sadler; Joel Dimsdale; Mairav Cohen-Zion; Lavinia Fiorentino
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

4.  Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls.

Authors:  Linda E Carlson; Tavis S Campbell; Sheila N Garland; Paul Grossman
Journal:  J Behav Med       Date:  2007-01-24

5.  Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients.

Authors:  S M Spencer; J M Lehman; C Wynings; P Arena; C S Carver; M H Antoni; R P Derhagopian; G Ironson; N Love
Journal:  Health Psychol       Date:  1999-03       Impact factor: 4.267

6.  Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial.

Authors:  Jack D Edinger; William K Wohlgemuth; Andrew D Krystal; John R Rice
Journal:  Arch Intern Med       Date:  2005-11-28

7.  Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery.

Authors:  K Shimozuma; P A Ganz; L Petersen; K Hirji
Journal:  Breast Cancer Res Treat       Date:  1999-07       Impact factor: 4.872

8.  Psychometric evaluation of the Pittsburgh Sleep Quality Index.

Authors:  J S Carpenter; M A Andrykowski
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

Review 9.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Authors:  Andrew H Miller; Sonia Ancoli-Israel; Julienne E Bower; Lucile Capuron; Michael R Irwin
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

10.  Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample.

Authors:  Daniel J Buysse; Martica L Hall; Patrick J Strollo; Thomas W Kamarck; Jane Owens; Laisze Lee; Steven E Reis; Karen A Matthews
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

View more
  19 in total

1.  Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Authors:  Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  Perceived stress as a mediator between social constraints and sleep quality among Chinese American breast cancer survivors.

Authors:  Nelson C Y Yeung; Jeffrey Ramirez; Qian Lu
Journal:  Support Care Cancer       Date:  2017-02-11       Impact factor: 3.603

3.  Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes.

Authors:  Kamala S Thomas; Julienne Bower; Michael A Hoyt; Saviz Sepah
Journal:  Psychooncology       Date:  2010-07       Impact factor: 3.894

4.  Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality.

Authors:  Ann M Berger; Kevin A Kupzyk; Dilorom M Djalilova; Kenneth H Cowan
Journal:  Support Care Cancer       Date:  2018-08-15       Impact factor: 3.603

5.  Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy.

Authors:  Joseph A Roscoe; Michael L Perlis; Wilfred R Pigeon; Kristen H O'Neill; Charles E Heckler; Sara E Matteson-Rusby; Oxana G Palesh; Michelle Shayne; Alissa Huston
Journal:  J Psychosom Res       Date:  2011-09-22       Impact factor: 3.006

6.  Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance.

Authors:  Christina Van Onselen; Bruce A Cooper; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Steven Paul; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2012-10       Impact factor: 3.603

7.  Characteristics and correlates of sleep disturbances in cancer patients.

Authors:  Kristin M Phillips; Heather S Jim; Kristine A Donovan; Mary C Pinder-Schenck; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2011-02-11       Impact factor: 3.603

8.  New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms.

Authors:  Huong Thi Xuan Hoang; Alex Molassiotis; Choi Wan Chan; Thi Huong Nguyen; Van Liep Nguyen
Journal:  Sleep Breath       Date:  2019-04-23       Impact factor: 2.816

9.  Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.

Authors:  Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-23       Impact factor: 5.742

10.  Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer.

Authors:  Christina Van Onselen; Steven M Paul; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Bruce Cooper; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2012-08-24       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.